BALTIMORE, MD, May 15, 2025 – As automation and globalization continue reshaping the workforce, high-paying jobs in traditionally male-dominated sectors are shrinking while demand for roles in healthcare, education and other “feminine” industries surges. But despite strong salaries and job security, men remain reluctant to enter these fields. Why? Groundbreaking new research in the INFORMS journal Organization Science has the answer – and a solution.
BALTIMORE, MD, May 13, 2025 – Researchers who took a close look at loosened concealed carry laws between 2010 and 2017 have found that “Shall Issue” regulations, which remove local authority discretion on the issuance of concealed carry gun permits, contribute to a significant increase in handgun purchases. At the same time, the researchers found that in states that adopted “Permitless Carry” policies, there was no noticeable change in gun purchases.
With sweeping new tariffs on Chinese-made products set to take effect this summer, Americans are being urged to prepare for price hikes on everyday goods. President Donald Trump's reinstated trade policies are expected to affect a wide swath of consumer imports, including electronics, furniture, appliances, and baby gear. Retail experts are advising shoppers to act before the tariffs hit and prices rise.
An audio journey of how data and analytics save lives, save money and solve problems.
Ashley Smith
Public Affairs Coordinator
INFORMS
Catonsville, MD
[email protected]
443-757-3578
Explore our resources for multiple topics including:
Loosening restrictions and the warmer weather are beginning to draw students outside where experts say gathering is safer — but still not risk free.
Tens of millions of people across the U.S. have received a coronavirus vaccine. So far, the majority of doses have been either the Moderna or Pfizer vaccine, both of which use mRNA to generate an immune response. These gene-based vaccines have been in the works for decades, but this is the first time they have been used widely in people.
The various Covid-19 vaccines currently being distributed around the globe have the potential to end the worst pandemic in a century. They also will mean hundreds of billions dollars in sales for the pharmaceutical companies that make them.
Good evening. I’m Deborah Netburn, a science and features writer at the Los Angeles Times, filling in for Thuc Nhi Nguyen for a few days. You may remember me from my previous stints with the newsletter — it’s nice to be back! It’s Monday, March 15, and here’s what’s happening with the coronavirus in California and beyond.
Developing the vaccines was a gamble for the all the companies that tried, even with most drug makers accepting government grands.
OR/MS Today is the INFORMS member magazine that shares the latest research and best practices in operations research, analytics and the management sciences.
Access OR/MS Today Magazine
Analytics magazine showcases articles and research reports based on big data, AI, machine learning, data analytics and other new-age technologies.
Access Analytics Magazine